Quest Diagnostics Incorporated Stock Probability of Future Stock Price Finishing Over 102.36

DGX Stock  USD 131.06  2.19  1.70%   
Quest Diagnostics' implied volatility is one of the determining factors in the pricing options written on Quest Diagnostics Incorporated. Implied volatility approximates the future value of Quest Diagnostics based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Quest Diagnostics Incorporated over a specific time period. For example, 2024-04-19 CALL at $130.0 is a CALL option contract on Quest Diagnostics' common stock with a strick price of 130.0 expiring on 2024-04-19. The contract was last traded on 2024-03-27 at 15:14:25 for $2.63 and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $2.9, and an ask price of $3.1. The implied volatility as of the 28th of March is 17.93. View All Quest options

Closest to current price Quest long CALL Option Payoff at Expiration

Quest Diagnostics' future price is the expected price of Quest Diagnostics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Quest Diagnostics Incorporated performance during a given time horizon utilizing its historical volatility. Check out Quest Diagnostics Backtesting, Quest Diagnostics Valuation, Quest Diagnostics Correlation, Quest Diagnostics Hype Analysis, Quest Diagnostics Volatility, Quest Diagnostics History as well as Quest Diagnostics Performance.
  
Price Earnings Ratio is likely to rise to 18.99 in 2024, whereas Price To Sales Ratio is likely to drop 1.18 in 2024. Please specify Quest Diagnostics' target price for which you would like Quest Diagnostics odds to be computed.

Quest Diagnostics Target Price Odds to finish over 102.36

The tendency of Quest Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 102.36  in 90 days
 131.06 90 days 102.36 
close to 99
Based on a normal probability distribution, the odds of Quest Diagnostics to stay above $ 102.36  in 90 days from now is close to 99 (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Stock to fall within a particular range of prices over 90 days) . Probability of Quest Diagnostics price to stay between $ 102.36  and its current price of $131.06 at the end of the 90-day period is about 57.05 .
Considering the 90-day investment horizon Quest Diagnostics has a beta of 0.43 suggesting as returns on the market go up, Quest Diagnostics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Quest Diagnostics Incorporated will be expected to be much smaller as well. Additionally Quest Diagnostics Incorporated has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Quest Diagnostics Price Density   
       Price  

Predictive Modules for Quest Diagnostics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quest Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quest Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
130.07131.24132.41
Details
Intrinsic
Valuation
LowRealHigh
117.95139.09140.26
Details
Naive
Forecast
LowNextHigh
130.82131.99133.16
Details
18 Analysts
Consensus
LowTargetHigh
133.14146.31162.40
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Quest Diagnostics. Your research has to be compared to or analyzed against Quest Diagnostics' peers to derive any actionable benefits. When done correctly, Quest Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Quest Diagnostics.

Quest Diagnostics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Quest Diagnostics is not an exception. The market had few large corrections towards the Quest Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Quest Diagnostics Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Quest Diagnostics within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.11
β
Beta against NYSE Composite0.43
σ
Overall volatility
4.82
Ir
Information ratio -0.16

Quest Diagnostics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quest Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quest Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Quest Diagnostics generated a negative expected return over the last 90 days
Quest Diagnostics has a strong financial position based on the latest SEC filings
Over 92.0% of the company shares are held by institutions such as insurance companies
On 31st of January 2024 Quest Diagnostics paid $ 0.71 per share dividend to its current shareholders
Latest headline from businesswire.com: U.S. Clinical Laboratory Tests Market Outlook Forecast 2024-2029 Featuring Prominent Vendors - Eurofins Scientific, Laboratory Corp of America, Mayo Clinic, OPKO, Quest Diagnostics, Siemens, Sonic - ResearchAndMarkets.com

Quest Diagnostics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quest Stock often depends not only on the future outlook of the current and potential Quest Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding113 M
Cash And Short Term Investments686 M

Quest Diagnostics Technical Analysis

Quest Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Quest Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Quest Diagnostics Incorporated. In general, you should focus on analyzing Quest Stock price patterns and their correlations with different microeconomic environments and drivers.

Quest Diagnostics Predictive Forecast Models

Quest Diagnostics' time-series forecasting models is one of many Quest Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Quest Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Quest Diagnostics

Checking the ongoing alerts about Quest Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Quest Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Quest Diagnostics generated a negative expected return over the last 90 days
Quest Diagnostics has a strong financial position based on the latest SEC filings
Over 92.0% of the company shares are held by institutions such as insurance companies
On 31st of January 2024 Quest Diagnostics paid $ 0.71 per share dividend to its current shareholders
Latest headline from businesswire.com: U.S. Clinical Laboratory Tests Market Outlook Forecast 2024-2029 Featuring Prominent Vendors - Eurofins Scientific, Laboratory Corp of America, Mayo Clinic, OPKO, Quest Diagnostics, Siemens, Sonic - ResearchAndMarkets.com
When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:
Check out Quest Diagnostics Backtesting, Quest Diagnostics Valuation, Quest Diagnostics Correlation, Quest Diagnostics Hype Analysis, Quest Diagnostics Volatility, Quest Diagnostics History as well as Quest Diagnostics Performance.
Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.868
Dividend Share
2.84
Earnings Share
7.48
Revenue Per Share
82.607
Quarterly Revenue Growth
(0.02)
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.